Actions

CD79a: Difference between revisions

From haematologyetc.co.uk

(Blanked the page)
Tag: Blanking
No edit summary
Line 1: Line 1:


<div style="background-color: #E0EEEE; {{round corners}} padding: 2em 2em;  margin-right: 5px;">
:<span style="color:navy">'''Summary'''</span>
:xxxx
</div>
<span style="color:navy">'''Normal expression and function'''</span>
xxxxx
<span style="color:navy">'''Diagnostic role'''</span>
*xxxxx
<span style="color:navy">'''Other relevant information:'''</span>
xxxxx
----
<span style="color:navy">'''''SUMMARY TABLES'''''</span>
<span style="font-size:90%">'''Note''' The colour and % refer to the proportion of cases expressing the marker. Additional comments on strength, or site of expression (if relevant) are given below the table. For full details of key click [[Key to marker expression table|here]]. For further information about a particular disease state click <<span style="color:blue>'''I'''</span>> adjacent to the condition name</span>
{| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
|-
!colspan="8"|<span style="font-size:100%">'''Expression in primitive cell types'''</font>
|-
! AML !! CMML !! B ALL !! Burkitt || T ALL !! ETP ALL <'''[[ETP ALL|I]]'''> !! MPAL <'''[[MPAL|I]]'''> || Hgns <'''[[Hgns|I]]'''>
|-
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|-
|}
<span style="font-size:90%">'''Notes:''' xxxxx </span>
{| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
|-
!colspan="8"|'''Expression in mature B cell neoplasms'''
|-
! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL || LPL !! PCL
|-
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 12.5%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|-
|}
<span style="font-size:90%">'''Notes:''' xxxxx </span>
{| class=wikitable style="text-align: center; font-size:80%; width: 62.4%; height 40px;"
|-
!colspan="7"|'''Expression in mature T cell neoplasms*'''
|-
! ATLL !! CTCL/Sezary !! T-PLL !! T-LGL !! NK-LGL
|-
|style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
|-
|}
<span style="font-size:90%">'''Notes:''' xxxxx </span>
----

Revision as of 09:15, 18 May 2023


Summary
xxxx



Normal expression and function

xxxxx


Diagnostic role

  • xxxxx



Other relevant information:

xxxxx



SUMMARY TABLES


Note The colour and % refer to the proportion of cases expressing the marker. Additional comments on strength, or site of expression (if relevant) are given below the table. For full details of key click here. For further information about a particular disease state click <I> adjacent to the condition name


Expression in primitive cell types
AML CMML B ALL Burkitt T ALL ETP ALL <I> MPAL <I> Hgns <I>
? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100%

Notes: xxxxx


Expression in mature B cell neoplasms
CLL MCL FL MZL HCL DLBCL LPL PCL
? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100%

Notes: xxxxx


Expression in mature T cell neoplasms*
ATLL CTCL/Sezary T-PLL T-LGL NK-LGL
? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100% ? <5% 5-20% 20-40% 40-80% 80-100%

Notes: xxxxx

Retrieved from ‘https://haematologyetc.co.uk/index.php?title=CD79a&oldid=1381’